Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia By Investing.com
Silo Pharma (SILO) Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), ...